CCIA
IMGN

Campbell & Co Investment Adviser’s Immunogen Inc IMGN Stock Holding History

Campbell & Co Investment Adviser’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-145,100
Closed -$1.08M – 951
2021
Q4 		$1.08M Buy
+145,100
New +$902K 0.37% 49
2021
Q3 		– Sell
-26,300
Closed -$173K – 827
2021
Q2 		$173K Buy
+26,300
New +$183K 0.07% 468
2015
Q4 		– Sell
-22,968
Closed -$220K – 272
2015
Q3 		$220K Buy
+22,968
New +$336K 0.15% 252

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Campbell & Co Investment Adviser's IMGN Position: Q1 2022 in Review

Campbell & Co Investment Adviser sold out of Immunogen Inc (IMGN) in Q1 2022, closing a stake of 145,100 shares — an estimated $1.08M sold.

Campbell & Co Investment Adviser first reported a position in IMGN in Q3 2015 and held it in 3 quarters. The position peaked at $1.08M in Q4 2021. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2022.

  • Campbell & Co Investment Adviser reported no remaining Immunogen Inc position as of Q1 2022 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 145,100 Immunogen Inc shares in Q1 2022, an estimated $1.08M.
  • Campbell & Co Investment Adviser first reported a position in Immunogen Inc in Q3 2015 and held it in 3 quarters.
  • Campbell & Co Investment Adviser's Immunogen Inc position peaked at $1.08M in Q4 2021.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2022.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2022, filed 9 May 2022.